A carregar...
Myelofibrosis in 2019: moving beyond JAK2 inhibition
Myelofibrosis (MF) is a myeloproliferative neoplasm characterized by ineffective clonal hematopoiesis, splenomegaly, bone marrow fibrosis, and the propensity for transformation to acute myeloid leukemia. The discovery of mutations in JAK2, CALR, and MPL have uncovered activated JAK-STAT signaling as...
Na minha lista:
| Publicado no: | Blood Cancer J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6739355/ https://ncbi.nlm.nih.gov/pubmed/31511492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-019-0236-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|